Sanaby Health Acquisition Corp. I (NASDAQ:SANBU) operates as a blank check company focused on effecting a merger, capital stock exchange, asset acquisition, stock purchase, or reorganization with one or more businesses, primarily targeting opportunities in the healthcare sector, including digital health, life science tools and services, and innovative therapeutics; it generates no revenues from products or services. Incorporated in Delaware in 2021 and headquartered in Palo Alto, California, the company completed an initial public offering in October 2021, raising $172.5 million through 15 million units at $10 each, with shares and warrants later trading separately under SANB and SANBW. In October 2022, unable to consummate an initial business combination within the required timeframe, Sanaby Health announced its dissolution and liquidation, redeeming all outstanding Class A common shares at approximately $10.22 per share, cancelling public shares effective October 19, 2022, and allowing warrants to expire worthless, with no subsequent merger, acquisition, or operational activity reported.